According to GlobalData’s medical device pipeline database, 26 Troponin Laboratory Tests devices are in various stages of development globally. GlobalData’s report Troponin Laboratory Tests provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, eight are in active development, while the remaining 18 are in an inactive stage of development. There are five products in the early stages of development, and the remaining three are in the late stages of development.

Troponin is a regulatory protein uniquely present on striated muscle which regulates the calcium – mediated interaction of actin and myosin. Cardiac troponins have additional amino acid residues on its N – terminal which is not present on the skeletal forms hence making them a promising analyte protein for indicating cardiac specificity. Cardiac troponin I is released rapidly (approx. 4 hrs.) to a detectable level after the onset of acute myocardial infarction. Troponin test is carried out with help of ELISA (Enzyme Linked Immunosorbent Assay) based kit which comprises of cardiac troponin I or cardiac troponin T with its control, calibrators, buffers and other accessories. One unit is defined as one test.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Troponin Laboratory Tests pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Troponin Laboratory Tests devices. Overall, most of these Troponin Laboratory Tests pipeline devices are being developed by private entities.

Key players involved in the active development of Troponin Laboratory Tests include Ortho Clinical Diagnostics, Roche Diagnostics International, Abbott Diagnostics, Beckman Coulter, Siemens Healthcare Diagnostics, Nanosphere, Siemens Healthineers, Singulex, Soroka University Medical Center and Tosoh Bioscience.

For a complete picture of the developmental pipeline for Troponin Laboratory Tests devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.